GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

被引：18

作者：

Sievers, Philipp ^{[1
,2
]}

Stichel, Damian ^{[1
,2
]}

Sill, Martin ^{[3
,4
]}

Schrimpf, Daniel ^{[1
,2
]}

Sturm, Dominik ^{[3
,5
,25
]}

Selt, Florian ^{[3
,5
,6
]}

Ecker, Jonas ^{[3
,5
,6
]}

Kazdal, Daniel ^{[7
]}

Miele, Evelina ^{[8
]}

Kranendonk, Marieatte E. G. ^{[9
]}

Tops, Bastiaan B. J. ^{[9
]}

Kohlhof-Meinecke, Patricia ^{[10
]}

Beschorner, Rudi ^{[11
]}

Kramm, Christof M. ^{[12
]}

Hasselblatt, Martin ^{[13
]}

Reifenberger, Guido ^{[14
,15
]}

Capper, David ^{[16
,17
,18
,19
]}

Wesseling, Pieter ^{[9
,20
,21
]}

Stenzinger, Albrecht ^{[7
]}

Milde, Till ^{[3
,5
,6
]}

Korshunov, Andrey ^{[1
,2
,3
]}

Witt, Olaf ^{[3
,5
,6
]}

Pfister, Stefan M. ^{[3
,4
,5
]}

Wick, Wolfgang ^{[22
,23
,24
]}

von Deimling, Andreas ^{[1
,2
]}

Jones, David T. W. ^{[3
,25
]}

Sahm, Felix ^{[1
,2
,3
]}

机构：

[1] Univ Hosp Heidelberg, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[2] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany

[3] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neurooncol, Heidelberg, Germany

[5] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany

[6] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany

[7] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany

[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Oncohematol & Cell & Gene Therapy, Rome, Italy

[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[10] Klinikum Stuttgart, Dept Pathol, Stuttgart, Germany

[11] Univ Tubingen, Dept Neuropathol, Tubingen, Germany

[12] Univ Med Ctr Gottingen, Div Pediat Hematol & Oncol, Gottingen, Germany

[13] Univ Hosp Munster, Inst Neuropathol, Munster, Germany

[14] Heinrich Heine Univ, Inst Neuropathol, Dusseldorf, Germany

[15] German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Dusseldorf, Germany

[16] Charite Univ Med Berlin, Berlin, Germany

[17] Free Univ Berlin, Berlin, Germany

[18] Humboldt Univ, Inst Neuropathol, Berlin, Germany

[19] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany

[20] Amsterdam Univ Med Ctr, Locat VUmc, Dept Pathol, Amsterdam, Netherlands

[21] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands

[22] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[23] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany

[24] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Neurooncol Program, Heidelberg, Germany

[25] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany

来源：

ACTA NEUROPATHOLOGICA | 2021年 / 142卷 / 06期

关键词：

CRIZOTINIB;

D O I：

10.1007/s00401-021-02369-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页码：1065 / 1069

页数：5

共 50 条

[1] GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers
Damian Stichel
Martin Sill
Daniel Schrimpf
Dominik Sturm
Florian Selt
Jonas Ecker
Daniel Kazdal
Evelina Miele
Mariëtte E. G. Kranendonk
Bastiaan B. J. Tops
Patricia Kohlhof-Meinecke
Rudi Beschorner
Christof M. Kramm
Martin Hasselblatt
Guido Reifenberger
David Capper
Pieter Wesseling
Albrecht Stenzinger
Till Milde
Andrey Korshunov
Olaf Witt
Stefan M. Pfister
Wolfgang Wick
Andreas von Deimling
David T. W. Jones
Felix Sahm
Acta Neuropathologica, 2021, 142 : 1065 - 1069
[2] Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations
Huang, Richard S. P.
Gottberg-Williams, Amanda
Vang, Panhia
Yang, Shoua
Britt, Nicholas
Kaur, Jaspreet
Haberberger, James
Danziger, Natalie
Owens, Clarence
Beckloff, Sara E.
Ross, Jeffrey S.
Ramkissoon, Shakti H.
JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (02):
[3] ROS1 fusions in cancer: a review
Uguen, Arnaud
De Braekeleer, Marc
FUTURE ONCOLOGY, 2016, 12 (16) : 1911 - 1928
[4] THE PRESENCE OF ROS1 FUSIONS ARE NOT LIMITED ONLY TO INFANTILE HEMISPHERIC GLIOMA
Trubicka, Joanna
Ciolkowski, Maciej
Perek-Polnik, Marta
Dembowska-Baginska, Bozenna
NEURO-ONCOLOGY, 2022, 24 : 65 - 65
[5] RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi
Manabu Soda
Yuki Togashi
Ritsuro Suzuki
Seiji Sakata
Satoko Hatano
Reimi Asaka
Wakako Hamanaka
Hironori Ninomiya
Hirofumi Uehara
Young Lim Choi
Yukitoshi Satoh
Sakae Okumura
Ken Nakagawa
Hiroyuki Mano
Yuichi Ishikawa
Nature Medicine, 2012, 18 : 378 - 381
[6] Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor
Kiehna, Erin N.
Arnush, Maxine R.
Tamrazi, Benita
Cotter, Jennifer A.
Hawes, Debra
Robison, Nathan J.
Fong, Cindy Y.
Estrine, Dolores B.
Han, Jennifer H.
Biegel, Jaclyn A.
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2017, 20 (01) : 51 - 55
[7] RET, ROS1 and ALK fusions in lung cancer
Takeuchi, Kengo
Soda, Manabu
Togashi, Yuki
Suzuki, Ritsuro
Sakata, Seiji
Hatano, Satoko
Asaka, Reimi
Hamanaka, Wakako
Ninomiya, Hironori
Uehara, Hirofumi
Choi, Young Lim
Satoh, Yukitoshi
Okumura, Sakae
Nakagawa, Ken
Mano, Hiroyuki
Ishikawa, Yuichi
NATURE MEDICINE, 2012, 18 (03) : 378 - 381
[8] Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma
Davare, Monika A.
Henderson, Jacob J.
Agarwal, Anupriya
Wagner, Jacob P.
Iyer, Sudarshan R.
Shah, Nameeta
Woltjer, Randy
Somwar, Romel
Gilheeney, Stephen W.
DeCarvalo, Ana
Mikkelson, Tom
Van Meir, Erwin G.
Ladanyi, Marc
Druker, Brian J.
CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6471 - 6482
[9] ROS1 as a Therapeutic Target in Advanced NSCLC
Wolf, Juergen
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S102 - S104
[10] Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion
Cerretti, Giulia
Padovan, Marta
Guerriero, Angela
Maccari, Marta
Bosio, Alberto
Caccese, Mario
Cella, Eugenia
Pintacuda, Giovanna
Librizzi, Giovanni
Lombardi, Giuseppe
NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)

← 1 2 3 4 5 →